Efficacy and safety of the new intravenous immunoglobulin IGIV 10% in adults with chronic idiopathic thrombocytopenic purpura

Authors
Category Primary study
JournalTransfusion Medicine and Hemotherapy
Year 2006
This article has no abstract
Epistemonikos ID: 04fbdd1dae42d8c24a597e93c4e50a432e580379
First added on: Nov 19, 2023